IL-35 Serum Levels in Bladder Cancer Patients: An Analytical Cross-sectional Study

Journal Title: Middle East Journal of Cancer - Year 2018, Vol 9, Issue 4

Abstract

Background: Bladder cancer is a prevalent disease with significant health care costs and high rates of recurrence. Results from numerous studies to associate bladder cancer with serum biomarkers have been analyzed for prognostic indicators, or to develop agents for diagnostic and therapeutic applications. Interleukin-35 is a suppressive cytokine that has a role in tumor immunity as a regulatory cytokine by suppressing T cell anticancer responses. Methods: In the present study, we have investigated interleukin-35 serum levels in bladder cancer patients by ELISA, and compared these levels with a healthy comparison group, as well as among different clinicopathological subgroups. Results: We observed no difference in serum levels of interleukin-35 in bladder cancer patients and healthy controls; however, bladder cancer patients diagnosed at lower stages (0a, I, II) had significantly higher levels of interleukin-35 in their sera compared to high stage (III, IV) patients (P=0.018). Conclusion: Our results could indicate that interleukin-35 has no significant role in bladder cancer pathogenesis and progression. Interleukin-35 might not be a valuable biomarker for diagnosis or assessment of bladder cancer progression in clinical settings. However, further studies are needed in order to reach a definitive conclusion.

Authors and Affiliations

Ali Ariafar, Sabereh Davari, Shabnam Abtahi, Abbas Ghaderi

Keywords

Related Articles

An Experimental Single-Case Design in Effectiveness of Oxytocin on Reducing Alcohol Addiction in a Patient with Oropharyngeal Carcinoma-the Mediation Role of Difficulties in Emotional Regulation

Oxytocin, due to its potential for modulation of cravings, is a possible alternative therapy for alcohol dependency. Management or cessation of alcohol use can increase the survival rates in cancers affected by alcohol a...

Thyroid-like Follicular Carcinoma of the Right Kidney: A Case Report

Renal cell carcinoma is responsible for approximately 80% of malignant tumors of the kidney. Clear cell, papillary, and chromophobe forms comprise the most frequent histological subtypes of renal cell carcinoma. Thyroid-...

A Comparison of Endothelial Cell-Selective Adhesion Molecule and von Willebrand Factor Expression in Breast Cancer Growth and Metastasis

Background: Angiogenesis is the process of new blood vessels formation that contribute to tumor growth and metastasis. Endothelial cell-selective adhesion molecule is one of the proteins that expresses in vascular endoth...

Assessment of Elevated Serum Tumor Markers Carcinoembryonic Antigen (CEA) and Cancer Antigen 15-3 (CA15-3) among Patients with Different Subtypes of Metastatic Breast Cancer

Background: Cancer antigen 15-3 and carcinoembryonic antigen are used in clinical and laboratory diagnosis of metastatic breast cancer. Previous studies have noted conflicting results about the association between carcin...

The Effectiveness of Group Acceptance and Commitment Psychotherapy on Psychological Well-being of Breast Cancer Patients in Shiraz, Iran

Background: Breast cancer is among the most prevalent types of cancers. Patients who suffer from cancer undergo many problems, including psychological complications. Acceptance and commitment psychotherapy can be used fo...

Download PDF file
  • EP ID EP658151
  • DOI -
  • Views 51
  • Downloads 0

How To Cite

Ali Ariafar, Sabereh Davari, Shabnam Abtahi, Abbas Ghaderi (2018). IL-35 Serum Levels in Bladder Cancer Patients: An Analytical Cross-sectional Study. Middle East Journal of Cancer, 9(4), -. https://europub.co.uk/articles/-A-658151